Sentiment Trading

ArriVent Biopharma Inc. is a biopharmaceutical company listed on the Nasdaq, with a market capitalization of $717.67 million, and a focus on developing innovative therapies to capitalize on emerging trends in the rapidly evolving healthcare sector.